Gross Profit for Gilead Sciences (GILD)
According to Gilead Sciences's latest reported financial statements, the company's current gross profit (TTM) is $23.79B USD. Gross profit equals revenue minus the cost of goods sold (COGS) — what remains from sales after the direct cost of producing the product or service. It does not yet subtract operating expenses, interest, or taxes (see operating income and net income for those steps). Higher gross profit (and gross margin) generally signals pricing power and production efficiency.
Headline TTM above sums the four reported quarters through (reported ). Chart and table below cover the full reported history back to .
GILD
Currently viewingGross ProfitSwitch metric
TTM (last 4 quarters)
$23.79B
YoY change
+13.4%
5Y CAGR
+4.9%
Peak year (2015)
$28.63B
Cumulative gross profit
$312.24B
Gross Profit history chart for Gilead Sciences (GILD) from 1990 to 2025
Gross Profit history table for Gilead Sciences (GILD) from 1990 to 2025
| Fiscal year | Period ended | Reported | Gross Profit | YoY |
|---|---|---|---|---|
| 2025 | $25.52B | +13.4% | ||
| 2024 | $22.50B | +9.1% | ||
| 2023 | $20.62B | -4.7% | ||
| 2022 | $21.62B | +4.4% | ||
| 2021 | $20.70B | +2.9% | ||
| 2020 | $20.12B | +13.2% | ||
| 2019 | $17.77B | +2.9% | ||
| 2018 | $17.27B | -20.5% | ||
| 2017 | $21.74B | -16.8% | ||
| 2016 | $26.13B | -8.7% | ||
| 2015 | $28.63B | +35.7% | ||
| 2014 | $21.10B | +152.9% | ||
| 2013 | $8.34B | +15.4% | ||
| 2012 | $7.23B | +15.5% | ||
| 2011 | $6.26B | +3.0% | ||
| 2010 | $6.08B | +12.3% | ||
| 2009 | $5.42B | +28.7% | ||
| 2008 | $4.21B | +21.6% | ||
| 2007 | $3.46B | +33.5% | ||
| 2006 | $2.59B | +46.6% | ||
| 2005 | $1.77B | +52.7% | ||
| 2004 | $1.16B | +53.3% | ||
| 2003 | $755.17M | +90.2% | ||
| 2002 | $397.07M | +109.0% | ||
| 2001 | $190.00M | +17.3% | ||
| 2000 | $162.04M | +6.5% | ||
| 1999 | $152.10M | +7.9% | ||
| 1998 | $140.90M | +11.9% | ||
| 1997 | $125.90M | +240.3% | ||
| 1996 | $37.00M | +527.1% | ||
| 1995 | $5.90M | -33.0% | ||
| 1994 | $8.80M | — | ||
| 1992 | $5.90M | +55.3% | ||
| 1991 | $3.80M | +81.0% | ||
| 1990 | $2.10M | — |
Gross Profit values are taken from Gilead Sciences's reported income statements (10-Q quarterly and 10-K annual filings with the U.S. Securities and Exchange Commission). Each row shows the period end date and the date the filing was reported; YoY compares each figure to the same period one year earlier. Amounts are in USD as filed.
Analysis
Gilead Sciences (GILD) most recent annual gross profit stands at $25.52B (2025) – grew 13.4% year-over-year.
Gilead Sciences gross profit has grown for 2 consecutive years, with a +4.9% compound annual growth rate over 2020–2025 (5 years).
Gilead Sciences gross profit peaked at $28.63B in 2015; the latest annual figure is $25.52B in 2025 (10.9% below peak).
2015 marks the peak gross profit at $28.63B, with the historical low of $2.10M recorded in 1990.
Within Healthcare, Gilead Sciences (GILD) ranks 9th among 8 peers we track. The peer median for gross profit is $53.80B.
Gilead Sciences Gross Profit by Year
Gilead Sciences Gross Profit 2025: $25.52B
Gilead Sciences gross profit in 2025 was $25.52B, grew 13.4% from 2024.
Gilead Sciences Gross Profit 2024: $22.50B
Gilead Sciences gross profit in 2024 was $22.50B, grew 9.1% from 2023.
Gilead Sciences Gross Profit 2023: $20.62B
Gilead Sciences gross profit in 2023 was $20.62B, edged down 4.7% below 2022.
Gilead Sciences Gross Profit 2022: $21.62B
Gilead Sciences gross profit in 2022 was $21.62B, edged up 4.4% from 2021.
Gilead Sciences Gross Profit 2021: $20.70B
Gilead Sciences gross profit in 2021 was $20.70B.
See more financial history for Gilead Sciences (GILD).
Sector peers — Gross Profit
Companies in the same sector as Gilead Sciences, ranked by their latest gross profit.
| Company | Gross Profit | Sector |
|---|---|---|
| Novo Nordisk A/S (NVO) | $250.28B | Healthcare |
| UnitedHealth Group Incorporated (UNH) | $82.92B | Healthcare |
| Johnson & Johnson (JNJ) | $68.56B | Healthcare |
| Eli Lilly and Company (LLY) | $54.62B | Healthcare |
| Merck & Co., Inc. (MRK) | $52.98B | Healthcare |
| AstraZeneca PLC (AZN) | $48.11B | Healthcare |
| AbbVie Inc. (ABBV) | $42.96B | Healthcare |
| Amgen Inc. (AMGN) | $26.01B | Healthcare |
Frequently asked questions
What is Gilead Sciences's gross profit?
- Latest reported gross profit for Gilead Sciences (GILD) is $23.79B (period ending December 31, 2025).
How has Gilead Sciences gross profit changed year-over-year?
- Gilead Sciences (GILD) gross profit changed +13.4% year-over-year on the latest annual filing.
What is the long-term growth rate of Gilead Sciences gross profit?
- Gilead Sciences (GILD) gross profit compound annual growth rate is +4.9% over the most recent 5 years available.
When did Gilead Sciences gross profit hit its highest annual value?
- Gilead Sciences gross profit reached its highest annual value of $28.63B in 2015.
What was Gilead Sciences gross profit in 2024?
- Gilead Sciences (GILD) gross profit in 2024 was $22.50B.
What was Gilead Sciences gross profit in 2025?
- Gilead Sciences (GILD) gross profit in 2025 was $25.52B.
Metrics overview
Pick a metric for charts, filings, and peers — each row shows the latest TTM or annual value with year-over-year change.
Explore more
GILD Overview
Company profile, financial tools, and key metrics
GILD Revenue Counter
Earns $933.60 every second. See per minute, hour, and day.
GILD Earnings Counter
Earns $269.85 per second net profit. See per minute, hour, and day.
GILD Economic Scale
Exceeds Albania's GDP. Compare with world economies.
GILD What If Invested
What if you had invested $1,000? See historical returns from any date.
GILD How It Makes Money
Discover visual breakdown of $29.44B in revenue — where it comes from and where it goes.
GILD Stock Seasonality
Best and worst months to invest. Historical monthly returns heatmap.
GILD Price Target Scenarios
Model bear, base, and bull cases with EPS growth and exit P/E — pre-filled from analysts and history.
GILD Daily Price Character
Explosive · 48.7% historical win rate (green days). Streaks & record days.
GILD Buybacks
1.26% TTM buyback yield. Shareholder yield & SBC comparison.
GILD Stock Split History
5 splits on record. Dates, ratios, and cumulative multiple.
GILD Dividend Profile
Yield: 2.48%. Safety: 8/8. See full history.
GILD Dividend Calculator
How much dividend income would $1,000 have earned? Calculate from any date.
GILD Dividend Forecast
Project future income with DRIP, growth assumptions, and optional monthly contributions.